Table 1.
IC50 Values (μM) and Selectivity Index of Cancer Cell Lines Treated With Compounds (6a-f) for 96 h.
|
Drug/cell line |
IC50 |
SI |
|||||
|---|---|---|---|---|---|---|---|
| HDF | U87 | MCF-7 | A549 | U87 | MCF-7 | A549 | |
| 6c | 293.6 ± 11.4 | 12.29 ± 5.5 | 61.56 ± 11.1 | 238.8 ± 7.9 | 23.9 | 4.8 | 1.2 |
| 6d | 425.2 ± 18.5 | 3.817 ± 2.9 | 123.5 ± 10.6 | 307.6 ± 12.1 | 111.4 | 3.4 | 1.4 |
| 6b | 170.7 ± 8.1 | 1.2 ± 0.8 | 10.58 ± 2.3 | 29.4 ± 6.2 | 142.3 | 16.1 | 5.8 |
| 6a | 504.2 ± 19.9 | 34.57 ± 7.8 | 112 ± 10.1 | 138.6 ± 9.3 | 14.6 | 4.5 | 3.6 |
| 6e | 83 ± 5.8 | 45 ± 7.1 | 58.6 ± 5.9 | 79 ± 4.7 | 1.8 | 1.4 | 1.1 |
| 6f | 141.7 ± 4.1 | 7.9 ± 2.3 | 10.6 ± 3 | 103.7 ± 4.5 | 18 | 13.3 | 1.4 |
| Cisplatin | 40.9 ± 5.4 | 28.3 ± 5.3 | 26.9 ± 4.7 | 30.4 ± 5.2 | 1.5 | 1.5 | 1.3 |